Blog

The Role of Mobile Technology in Kenya Healthcare

In a report released last year by Statista [i], Kenya is the leading consumer of internet via use of smartphones in the world. This has been attributed to the country’s high level of smartphones penetration...

Read More »

Generic drugs or Branded drugs: Which is better?

Pharmaceutical companies still invest billions of dollars over several years in order to get their drug pipeline of product(s) approved, registered and patent protected to maximise profits from such brand ownership in a highly competitive...

Read More »

New i3 Consult Video

i3 Consult is proud to announce the promotion of its new premium strategic marketing, financial and operational management solutions package for healthcare, pharmaceutical and other life science organisations via the release of its You Tube...

Read More »

Launch of Our i3 QoW Page

i3 Consult is proud to announce the launch of its i3 QoW Web page - https://www.i3consult.com/quote-of-the-week/. This Web content is based on an extraordinary collection of more than a year of Quotes of the Week (QoW)...

Read More »

iClinical: Data platform for virtual clinical trials

As part of i3 Consult’s partnership with iClinical, we are pleased to announce the launch of iClinical’s Data Platform for Virtual Clinical Trials mobile app. This technology is destined to leverage clinical trial management and...

Read More »

Changes to our website www.i3Consult.com

Hi there, i3 Consult is proud to announce the launch of new content for www.i3consult.com. As shown on our i3 Services page, this launch is to reflect our new service offer of greater niche consultancy solutions for  “4Ps” sectors...

Read More »

iClinical and i3 Consult Partnership Announcement

Hi there, We are pleased to announce i3 Consult is partnering with iClinical to support our services in clinical trial management. iClinical provides a customised mobile/cloud data platform to collect and analyse clinical trial data...

Read More »

Pharmacovigilance : Challenges & Opportunities

The competitiveness of drug development has been the impetus for new and accelerated regulatory pathways. While the growing patient-centric healthcare market coupled with a vested interest in safety information from a range of governmental and...

Read More »